135 related articles for article (PubMed ID: 11030463)
1. ADP-induced platelet shape change: an investigation of the signalling pathways involved and their dependence on the method of platelet preparation.
Wilde JI; Retzer M; Siess W; Watson SP
Platelets; 2000 Aug; 11(5):286-95. PubMed ID: 11030463
[TBL] [Abstract][Full Text] [Related]
2. Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Hardy AR; Hill DJ; Poole AW
Platelets; 2005 Nov; 16(7):415-29. PubMed ID: 16236603
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
Jin J; Daniel JL; Kunapuli SP
J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
[TBL] [Abstract][Full Text] [Related]
4. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change.
Paul BZ; Daniel JL; Kunapuli SP
J Biol Chem; 1999 Oct; 274(40):28293-300. PubMed ID: 10497186
[TBL] [Abstract][Full Text] [Related]
5. Convulxin induces platelet shape change through myosin light chain kinase and Rho kinase.
Riondino S; Gazzaniga PP; Pulcinelli FM
Eur J Biochem; 2002 Dec; 269(23):5878-84. PubMed ID: 12444976
[TBL] [Abstract][Full Text] [Related]
6. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
7. Involvement of a calcium-independent pathway in plasmin-induced platelet shape change.
Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
Life Sci; 2001 Jul; 69(8):945-60. PubMed ID: 11488407
[TBL] [Abstract][Full Text] [Related]
8. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
[TBL] [Abstract][Full Text] [Related]
9. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
10. Effect of clopidogrel administration to healthy volunteers on platelet phosphorylation events triggered by ADP.
Contreres JO; Dupuy E; Job B; Habib A; Bryckaert M; Rosa JP; Simoneau G; Herbert JM; Savi P; Levy-Toledano S
Br J Haematol; 2003 Feb; 120(4):633-42. PubMed ID: 12588350
[TBL] [Abstract][Full Text] [Related]
11. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
12. Platelet collagen receptor integrin alpha2beta1 activation involves differential participation of ADP-receptor subtypes P2Y1 and P2Y12 but not intracellular calcium change.
Jung SM; Moroi M
Eur J Biochem; 2001 Jun; 268(12):3513-22. PubMed ID: 11422381
[TBL] [Abstract][Full Text] [Related]
13. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
Jagroop IA; Burnstock G; Mikhailidis DP
Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
[TBL] [Abstract][Full Text] [Related]
14. Dichotomous regulation of myosin phosphorylation and shape change by Rho-kinase and calcium in intact human platelets.
Bauer M; Retzer M; Wilde JI; Maschberger P; Essler M; Aepfelbacher M; Watson SP; Siess W
Blood; 1999 Sep; 94(5):1665-72. PubMed ID: 10477691
[TBL] [Abstract][Full Text] [Related]
15. Mildly oxidised low density lipoprotein induces platelet shape change via Rho-kinase-dependent phosphorylation of myosin light chain and moesin.
Retzer M; Siess W; Essler M
FEBS Lett; 2000 Jan; 466(1):70-4. PubMed ID: 10648815
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide.
Missy K; Plantavid M; Pacaud P; Viala C; Chap H; Payrastre B
Thromb Haemost; 2001 Mar; 85(3):514-20. PubMed ID: 11307824
[TBL] [Abstract][Full Text] [Related]
17. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Fälker K; Lange D; Presek P
Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804
[TBL] [Abstract][Full Text] [Related]
18. Effects of enhanced P2X1 receptor Ca2+ influx on functional responses in human platelets.
Rolf MG; Mahaut-Smith MP
Thromb Haemost; 2002 Sep; 88(3):495-502. PubMed ID: 12353081
[TBL] [Abstract][Full Text] [Related]
19. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase.
Suzuki Y; Yamamoto M; Wada H; Ito M; Nakano T; Sasaki Y; Narumiya S; Shiku H; Nishikawa M
Blood; 1999 May; 93(10):3408-17. PubMed ID: 10233893
[TBL] [Abstract][Full Text] [Related]
20. P2 receptors and platelet activation.
Kunapuli SP
ScientificWorldJournal; 2002 Feb; 2():424-33. PubMed ID: 12806027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
